You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 8, April 25, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (30)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Surgery
 •Vascular Surgery
 •Prognosis/ Outcomes
 •Alert me on articles by topic

Optimizing the Prediction of Perioperative Mortality in Vascular Surgery by Using a Customized Probability Model

Miklos D. Kertai, MD, PhD; Eric Boersma, PhD; Jan Klein, MD, PhD; Hero van Urk, MD, PhD; Don Poldermans, MD, PhD

Arch Intern Med. 2005;165:898-904.

Background  Accurately assessing the probability of perioperative mortality can be useful in preoperative risk assessment and management. This study aimed to revise and customize the revised cardiac risk (Lee) index to estimate the probability of perioperative all-cause mortality in patients undergoing noncardiac vascular surgery.

Methods  We studied 2310 patients (mean age, 67.8 ± 11.3 years; 1747 males) who underwent acute or elective major noncardiac vascular surgery between January 1, 1991, and December 31, 2000, at the Erasmus Medical Center, Rotterdam, the Netherlands. A total of 1537 patients were assigned for model development, in which the associations between predictor variables and mortality occurring within 30 days after surgery were identified to modify the Lee index, which was then evaluated in a validation cohort of 773 patients.

Results  The perioperative mortality rates were similar in the development (n = 103 [6.7%]) and validation (n = 50 [6.5%]) populations. The customized risk-prediction model for perioperative mortality identified type of vascular surgery, ischemic heart disease, congestive heart failure, previous stroke, hypertension, renal dysfunction, and chronic pulmonary disease as being associated with increased risk, whereas {beta}-blocker and statin use were associated with a lower risk of mortality. The performance of the customized index had excellent discriminative ability in both derivation and validation populations (concordance statistic, 0.88 and 0.85, respectively).

Conclusions  The customized index provides more detailed information than the Lee index about the type of vascular procedure, clinical risk factors, and concomitant medication use. The customized probability model can be a useful tool to estimate the risk of perioperative all-cause mortality and facilitate subsequent treatment strategies.


Author Affiliations: Departments of Cardiology (Drs Kertai and Boersma), Anesthesiology (Drs Klein and Poldermans), and Vascular Surgery (Dr van Urk), Erasmus Medical Center, Rotterdam, the Netherlands.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery
Kertai et al.
Br J Anaesth 2008;101:458-465.
ABSTRACT | FULL TEXT  

Preoperative cardiac risk assessment in vascular surgery patients: seeing beyond the perioperative period
Schouten et al.
Eur Heart J 2008;29:283-284.
FULL TEXT  

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery
Fleisher et al.
J Am Coll Cardiol 2007;50:e159-e242.
FULL TEXT  

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery)
Fleisher et al.
Circulation 2007;116:e418-e500.
FULL TEXT  

Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery
Feringa et al.
Heart 2007;93:226-231.
ABSTRACT | FULL TEXT  

Protecting the Heart with Cardiac Medication in Patients with Left Ventricular Dysfunction Undergoing Major Noncardiac Vascular Surgery
Feringa et al.
SEMIN CARDIOTHORAC VASC ANESTH 2006;10:25-31.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.